• Peripheral Vascular Disease eLearning Course


    Course Director

    Christopher White, MD, FSCAI
    Professor of Medicine
    System Chairman for Cardiovascular Diseases
    The John Ochsner Heart and Vascular Institute
    New Orleans, LA


    Target Audience

    This program is targeted to physicians and fellows-in-training and will offer didactic education on basic knowledge, potential complications, and treatment options for PVD patients based on the latest information and best practices in this growing area of interventional cardiovascular medicine.


    Learning Objectives  
    This course is no longer available for Continuing Medical Education credits.

    The PVD course is designed to enhance knowledge and understanding of PVD through the following learning objectives:

    • Discuss the pathophysiology and natural history of peripheral vascular disease;
    • Recognize the appropriate diagnostic studies for evaluation of peripheral vascular disease;
    • Recall the appropriate medical therapies for different types of peripheral vascular disease;
    • Differentiate between the options for surgical and catheter-based treatment for iliac, renal, lower extremity, brachiocephalic, aortic and carotid disease;
    • Identify the appropriate equipment and techniques for interventional treatment of iliac, lower extremity, renal, aortic, brachiocephalic and carotid disease;
    • Select appropriate cases for interventional and surgical therapy of PVD


    Content Validation Statement

    The Society for Cardiovascular Angiography and Interventions accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements with regard to any recommendations for clinical care.

    All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contradictions in the care of patients; AND/OR

    All scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.


    Faculty Disclosures

    Ramy Badawi, MD Nothing to disclose
    Arindam Banerjee, MD Nothing to disclose
    John Bittl, MD Nothing to disclose
    Zehra Jaffrey, MD Nothing to disclose
    J. Stephen Jenkins, MD Nothing to disclose
    Andrew Kline, MD Nothing to disclose
    Amit Prasad, MD Nothing to disclose
    Jonathan Rapp, MD Nothing to disclose
    James Schipper, MD Nothing to disclose
    Yabiz Sedghi, MD Nothing to disclose
    Anil Verma, MD Nothing to disclose
    Christopher White, MD, FSCAI Advisory Board: St Jude, Neovasc, Baxter Cellular Therapy; Consultant: Boston Scientific, Neovasc


    Disclosure Statement

    As a provider of continuing education through the Accreditation Council for Continuing Medical Education (ACCME), it is the Society's policy to ensure balance, independence, objectivity and scientific rigor in all of its programs. All participating faculty, course directors, and planning committee members are required to disclose to SCAI any financial relationships related to the subject matter of the program or committee in which they are participating. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of the disclosure is not to prevent the planner or presenter from being involved in the activity, but rather to provide participants with information on which they can make their own judgments.


    Commercial Support

    This program is supported by educational grants from Cook Medical and Abbott Laboratories.